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Abstract
In HIV infection there is a paucity of literature about the degree of immune dysfunction to potentially correlate and/or
predict disease progression relative to CD4
+ T cells count or viral load. We assessed functional characteristics of memory T
cells subsets as potential prognostic markers for changing viral loads and/or disease progression using the SHIV-infected
rhesus macaque model. Relative to long-term non-progressors with low/undetectable viral loads, those with chronic plasma
viremia, but clinically healthy, exhibited significantly lower numbers and functional impairment of CD4
+ T cells, but not
CD8
+ T cells, in terms of IL-2 production by central memory subset in response to PMA and ionomycine (PMA+I) stimulation.
Highly viremic animals showed impaired cytokine-production by all T cells subsets. These results suggest that functional
impairment of CD4
+ T cells in general, and of central memory subset in particular, may be a potential indicator/predictor of
chronic infection with immune dysfunction, which could be assayed relatively easily using non-specific PMA+I stimulation.
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Introduction
Human immunodeficiency virus (HIV) infection exerts pro-
found effects on the immune system in terms of effectively evading
the antiviral antibody responses as well as progressively compro-
mising the functional abilities of the cellular immune responses
that lead to the development of acquired immunodeficiency
syndrome (AIDS) characterized by life-threatening opportunistic
infections and malignancies [1,2]. Even though the mechanism by
which HIV replication disables the immune system is still unclear,
measurements of the patient’s CD4
+ T cell counts and plasma
viral load have long been the benchmarks of immunologic
assessment of disease progression and staging of infection [1,3].
However, reports in the recent past indicated CD4
+ T cell count
and viral load could not fully predict the disease progression, but
their functional characterization may be important [4,5]. Indeed,
vigorous HIV-1 specific CD4
+ T cells responses were shown to be
associated with the control of viremia in individuals who received
anti-viral treatment during acute HIV-1 infection [6]. Several
assays capable to detect antigen-specific T cells have since been
developed, and among these flow cytometry based on the ability to
detect cytokine production at the single cell level allows
simultaneous detection, quantization and phenotypic character-
ization of CD4
+ and CD8
+ T cells [7]. Using flow cytometry to
measure intracellular cytokines after stimulation of peripheral
blood mononuclear cells (PBMC) with recombinant HIV proteins
or overlapping peptide pools, HIV-specific CD4
+ T cells were
detected in individuals with active HIV-1 infection that declined
with prolonged viral suppression [8]. These results suggest the
importance of functional HIV-1 specific CD4
+ T cells for the
support of anti-HIV-1 effector responses in active disease.
However, because HIV-specific T cells are usually in limiting
numbers, it is difficult to perform repetitive assays with multiple
specific stimulators. Furthermore, it is not yet clear whether
antigen stimulation through the T-cell receptor, in combination
with co-stimuli, is capable in vitro of inducing adequate cytokine
expression measurable by current technologies. Therefore, it is
important to identify more prognostic markers based on the use of
generalized reagents that reflect changing viral loads and/or
disease progression. In this study, using the rhesus macaque
nonhuman primate model we investigated whether functional
properties of total and memory subsets of CD4
+ and CD8
+ T cells
would be a potential correlate of viral loads in the blood as a
reliable and easier approach. The SIV/SHIV infection of rhesus
macaques is the leading animal model of choice by many because
it recapitulates many of the features of HIV infection and disease
in humans, including CD4
+ T cells depletion and the slew of
opportunistic infections and malignancies [9,10,11]. We describe
here multicolor flow cytometry analyses combining detailed
phenotypic and functional characterization of total as well as
memory subsets of CD4
+ and CD8
+ T cells from SHIV-infected
rhesus macaques with no clinical symptoms but exhibiting
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19607markedly differing viral loads associated with differential cytokine
production in response to non-specific in vitro stimulation with
PMA+I.
Materials and Methods
Animals
Rhesus macaques used in this study are colony-bred animals of
Indian origin (Macaca mulatto) housed in the specific pathogen-free
colony fully accredited by the Association for Assessment and
AssociationofLaboratoryAnimalsCareInternationaland thestudy
was conducted according to NIH guidelines on Care and Use of
Laboratory Animals. Cryopreserved peripheral blood mononuclear
cells (PBMC) samples from a total 20 rhesus macaques experimen-
tally infected with SHIV89.6P or SHIVKU2 by the intravenous route
in previously published studies [12,13] were used for the studies in
this investigation. The PBMC for this investigation were isolated
from the blood samples collected at necropsy of the animals which
varied between week 18 and 89 post-challenge, depending on the
euthanization performed due to AIDS-related symptoms or end of
the study. Plasma SIV RNA levels were determined by real-time
RT-PCR analysis at the NIH core facility, as described previously
[14]. The threshold sensitivity of the real-time RT-PCR assay is
,100 RNA copy equivalents/ml of plasma with an inter-assay
variation ,25% (coefficient of variation). The viral loads in these
animals ranged from ,100 to 26610
6 copies/ml. Based on the
plasma viral loads the monkeys were stratified arbitrarily in to three
groups: long-term non-progressors (LTNP; n=10) with low to
undetectable viral loads (,1.0610
2 to 5.1610
2 copies/ml),
chronically infected but clinically healthy (Chronic; n=5) with
moderate vial loads (0.1610
4 to 6.1610
4copies/ml), and highly
viremic (Viremic; n=5) exhibiting high viral loads (0.18610
6 to
26610
6copies/ml) and with AIDS-defining complications (includ-
ing: weight loss, retroviral pneumonia, pleural fibrosis, type II
pneumocyte hyperplasis, diarrhea, wasting, generalized encephalitis
with malacia and gliosis multifocally in the brain).
Cells stimulation
Cryopreserved PBMC samples were removed from liquid
nitrogen and were rapidly thawed in a 37uC water bath, gently
mixed, washed with RPMI-1640 (HyClone laboratories, Logan,
UT) to remove the freezing medium and re-suspended in complete
media (CM; RPMI-1640 supplement with 10% heat-inactivated
FCS (HyClone laboratories), 2 mM L-glutamine (Sigma-Aldrich),
100 U/ml penicillin/streptomycin (Invitrogen), for culturing in 6-
well tissue culture plates overnight at 37uC in a humidified 5%
CO2 atmosphere. The next morning the viable cell counts were
determined by the trypan-blue dye exclusion and adjusted to
10610
6/ml with CM. Cells were stimulated for intracellular
cytokine staining as following: Aliquots of 0.1 ml cells suspensions
(1610
6 cells) were placed in 96 wells tissue culture plate (BD
Biosciences, Franklin lake, NJ) and cultured with phorbol 12-
myristate 13-acetate (PMA) at 50 ng/ml and Ionomycin (I) at
500 ng/ml (both from Sigma-Aldrich, St. Louis, MO), in a total
volume of 0.2 ml. An additional aliquot of the cells suspension
without PMA+I served as negative control. The cells were cultured
for 1.5 h before adding brefedin A (Sigma-Aldrich, St. Louis, MO)
at 10 mg/ml (to prevent cytokine secretion from the cells), for an
additional 4.5 h, to a total stimulation for 6 h. Subsequently, the
cells were harvested by washing in cold (4uC) flow wash buffer
(Dulbecco’s PBS (DPBS, Ca2
+/Mg2
+-free; Life technologies,
Rockville, MD, with 2% heat-inactivated FCS, HyClone labora-
tories) and then processed for staining various fluorescence labeled
antibodies. As reported earlier, brefeldin A treatment not only is
useful to retain cytokines within the cell cytoplasm, but also to
sustain expression of any induced cells surface molecules [15].
Indeed, in this study we observed that stimulation of PBMC for a
total of 6 hours (1.5 h with medium or PMA+I and the last 4.5 h
in the presence of brefeldin A), caused no changes in the surface
phenotype of the different cells subsets analyzed (data not shown).
Antibodies
The fluorescence-labeled monoclonal antibodies CD3 PE-Cy7
(SP34-2), CD8 Alexa700 (RPA-T8), CD28 PerCP-cy5.5 (L293),
CD95 (DX2), IFN-c FITC (B27), IL-2 PE (MQ1-17H12) and
IgG1 and IgG2 isotype matched controls were obtain from BD
Biosciences (San Jose, CA). The monoclonal antibody CD4 Pacific
blue (OKT4) was obtained from eBiosciences (San Diego, CA).
The live-dead fixable dead cells stain kit was obtained from
Invitrogen (Carlsbad, CA).
Immunofluorescence staining and flow cytometry
analysis
The intracellular cytokine staining assay was performed as
described previously [16]. Briefly, stimulated cells were first stained
with live/dead fixable aqua fluorescent reactive dye at 4uCi nt h e
dark for 30 minutes and washed once with cold flow wash buffer.
Then, the appropriately titrated antibodies to cell surface were
added to the cells and incubated for 30 minutes at 4uC in the dark.
Both compensation controls and fluorescence minus one (FMO)
controls were utilized. Surface stained cells were then washed with
cold flow wash buffer and fixed in fixation solution (BD Biosciences;
San Jose, CA) for at least 10 minutes before performing intracellular
cytokine staining. Fixation/permabilization solution was used for
intracellular cytokine staining following manufacturer’s instructions
(BD Biosciences; San Jose, CA). Appropriately titrated FITC-
labeled anti- IFN-c (B27) and PE-labeled anti-IL-2 (MQ1-17H12)
were added to the permeabilized cells for 60 minutes at 4uC in the
dark, followed by washing twice with permeabilization solution.
After the final wash, the cells were re-suspended in 1%
paraformaldehyde in DPBS and subjected to Flow cytometry
analysis within 24 hours. The stained cells were acquired on a LSR
II flow cytometer (BD Biosciences; San Jose, CA) or Cyan ADP
(Dako, Carpinteria, CA), and FACS data were analyzed by using
FlowJo software (Tree Star, Ashland, OR). In order to perform
uniform analyses across the three groups of animals at different
stages of SHIV infection, as defined by viral loads, we normalized
the percentages of total T cells and the different subsets to an
arbitrary total of 10,000 input peripheral blood lymphocytes (PBL).
Statistics
Data are represented as mean 6 SEM. The significance of
differences between groups was determined using the unpaired,
two-sided Student’s t test, and P values ,0.05 were considered
significant different.
Results and Discussion
We used multicolor flow cytometry analyses to investigate the
functional features paralleling the circulating total and memory
subsets of CD4
+ and CD8
+ T cells in SHIV-infected rhesus
macaques exhibiting varying levels of plasma viral loads along with
or without clinical symptoms. Peripheral blood mononuclear cells
(PBMC) collected from a total of 20 rhesus macaques at the
necropsy and preserved at liquid nitrogen were used for the
multicolor flow cytometry analyses. These 20 animals were used in
the past for vaccine studies [12,13] and changes in viral loads and
CD4
+ T cell counts were recorded for approximately one year post-
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or absence of clinical symptoms at necropsy the animals were
grouped as long-term non-progressors (LTNP, n=10), chronically
infected but healthy (Chronic, n=5), and symptomatic with high
viral loads (Viremic, n=5), as described in the Methods section.
The gating scheme used for the eight-color flow cytometry analyses
of the different T cells subsets from a representative animal is shown
in Fig. 1. The lymphocytes were first gated based on forward scatter
(FSC)versussidescatter(SSC)withthedeadcellsexcludedusingthe
violet live/dead stain. The live T cells were then positively identified
based on CD3 expression followed by detecting CD4
+ CD8
2
(CD4
+ T cells) and CD4
2 CD8
+ (CD8
+ T cells) populations. On the
basis of CD28 and CD95 expression, the CD4
+ and CD8
+ T cells
were further differentiated into naı ¨ve (Tn CD28
+ CD95
2), central
memory (Tcm CD28
+ CD95
+) and effector memory (Tem CD28
2
CD95
+) subsets as described in the literature [15]. Next, the total
and the different subsets of CD4
+ and CD8
+ T cells were assessed
for functional capacity in terms of cytokine production (IFN-c and/
or IL-2) in response to stimulation with PMA and ionomycin
(PMA+I). This analysis enabled identification of three functionally
distinct populations of total as well as memory subsets of CD4
+,
CD8
+ T cells, each producing IFN-c and IL-2 alone or the two
cytokines together (Fig. S2). Since these cytokines are important for
sustaining memory (IL-2) and mediating effector function (IFN-c),
this analysis provides a snap shot of the quantity and quality of the
inherentcell-mediatedimmunityinrelationtoviralload inthe three
different groups of monkeys studied.
Numbers of total CD4
+ and CD8
+ T cells are differentially
associated with viral loads
The CD4
+ T cells play an important role in maintaining
effective immunity against viral pathogens, specifically by
providing help to B cells for antiviral antibody production and
to cytotoxic T lymphocytes (CTL) for eliminating virus-infected
cells [17,18]. We first examined the numbers of total CD3
+ T cells
as well as CD4
+ and CD8
+ T cells subsets in all the animals tested
and representative data from one animal each in the three
different groups (Fig. 2A). As described in the methods section, in
order to perform uniform analyses across the three groups of
animals as defined by viral loads, we normalized the data for the
phenotypic and functional properties of the different subsets of T
cells to an arbitrary total number of 10,000 input peripheral blood
lymphocytes (PBL). Based on this criterion we observed that the
number of total CD3
+ T cells in the LTNP group (66766254;
Mean 6 SEM) were significantly higher (p=0.0123) compared to
that in the Chronic group (54936362) and also the Viremic group
(55596555; p=0.0441), but no differences were noted between
the Chronic and the Viremic groups (Fig. 2B). With regards to the
CD4
+ T cells, the mean number in the LTNP (37096255) was
significantly higher (p,0.0001) than that in the Chronic group
(13626163) and the Viremic group (464696; p=0.0002), as well
as between the LTNP and the Viremic groups (p,0.0001). These
results obtained using the arbitrarily selected total number of
10,000 PBL for the analyses are consistent with literature norms
showing that both the Chronic and Viremic groups of monkeys
with medium to higher viral loads exhibited significantly lower
numbers of CD4
+ T cells. The number of CD8
+ T cells exhibited a
reverse trend with the LTNP group (29016145) significantly lower
(p,0.0001) than the Viremic group (50426519) and also the
Chronic group (40816459; p=0.0043), but no differences were
observed between the Chronic and the Viremic groups.
Association of higher viral loads with decreased number
of central memory and naı ¨ve subsets of CD4
+ T cells
It has been shown that both CD4
+ and CD8
+ T cells can be
divided into two major memory subsets as central memory (Tcm)
Figure 1. Gating scheme for the analyses of the different T cell subsets in the peripheral blood mononuclear cells (PBMC) from a
representative animal. The lymphocytes were first gated based on forward scatter (FCS) versus side scatter (SSC), and then live lymphocytes were
identified based on SSC and aqua-negative population. The T cells were then positively identified by CD3 expression followed by the detection of the
CD4
+ CD8
2 (CD4
+ T cells) and CD4
2 CD8
+ (CD8
+ T cells) populations within the CD3
+ T cells. On the basis of CD28 and CD95 expression, the CD4
+ and
CD8
+ T cells were further differentiated into naı ¨ve (Tn CD28
+ CD95
2), central memory (Tcm CD28
+ CD95
+) and effector memory (Tem CD28
2 CD95
+)
subsets.
doi:10.1371/journal.pone.0019607.g001
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expression of phenotypic markers [19,20] In particular, Tcm cells
expressing CD28, CD95, CCR7 and CD62L home to lymph
nodes, whereas Tem do not express CD28 or CCR7 and home to
peripheral tissues that serve as effector sites [11,21]. In case of
nonhuman primates the Tcm and Tem subsets of CD4
+ and
CD8
+ T cells can be identified on the basis of differential
expression of CD28 and CD95 markers [15]. Using these markers
we analyzed for central memory (CD28
+ CD95
+) and effector
memory (CD28
2 CD95
+) subsets as well as naı ¨ve population
(CD28
+ CD95
2) within the CD4
+ CD8
2 and CD4
2 CD8
+ T cells
and representative FACS analysis patterns for one animal each for
the three different groups are shown in Fig. 3A. Similar to reports
in the literature [15] we did not observe changes in the levels of
surface expression of CD28 and CD95 after treatment with PMI +
I along with brefeldin A (data not shown). The Tem and Tcm
Figure 2. Flow cytometry analyses showing the distribution of total CD3
+ T cells along with subsets CD4
+ CD8
2 (CD4
+ T cells) and
CD4
2 CD8
+ (CD8
+ T cells). Panel A: data from a representative animal from each of the three groups of macaques with different viral loads: Long-
term non-progressors (LTNP), chronic viremia (Chronic), and highly viremic (Viremic). Panel B: comparison of the average values for the numbers of
total CD3
+ T cells as well as CD4
+ CD8
2 and CD4
2 CD8
+ T cells subsets in all the animals studied in the LTNP, Chronic and Viremic groups of monkeys.
The data are shown as the mean 6 SEM. The Horizontal bars represent the group mean, error bars represent SEM. Statistical differences between
groups are indicated by the p values.
doi:10.1371/journal.pone.0019607.g002
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+ and CD8
+ T cells were clearly evident even in the
Viremic group of monkeys despite total numbers of CD3
+ T cells
being the lowest among the three groups. However, relative to that
in the LTNP group monkeys, fewer numbers of naı ¨ve subsets of T
cells were observed in the Chronic group animals and almost none
were detectable in the Viremic group animals. In general, the Tem
and Tcm subsets of both CD4
+ and CD8
+ T cells were clearly
detectable in all three groups of animals (Fig. 3B and 3C,
respectively). Comparative analyses of the different subsets of
CD4
+ T cells (Fig. 3B) revealed that the number of CD4
+ Tcm in
the LTNP group (22356168, Mean 6 SEM) was significantly
higher (p,0.0001) compared to that in the Chronic group
(585674), which was in turn significantly higher (P,0.0001) than
that in the Viremic group (118622). There was also significant
difference for the Tcm number between animals in the LTNP and
the Viremic groups (p,0.0001). The number of naı ¨ve CD4
+ T
cells (CD4 Tn) in the animals in both the Viremic group (3969)
and the Chronic group (4069) were significantly lower
(p=0.0072) when compared to that in the LTNP group
(289660) but no differences were observed for this population
between the Chronic and the Viremic groups. These observations
describing the significant loss of naı ¨ve CD4
+ T cells (CD4 Tn) in
the animals in both the Viremic group and the Chronic group,
relative to that in the LTNP group, are in agreement with similar
results reported in the literature [22]. There was no significant
difference observed in the number of CD4 Tem (CD28
2 CD95
+)
cells between the LTNP (11376140) and the Chronic groups
(6966119), but the numbers in the Viremic group (279665) were
significantly lower compared to that in the LTNP and the Chronic
groups (p=0.0066 and 0.0003, respectively). In contrast to the
CD4
+ T cells subsets, we observed no differences in the
frequencies for the numbers of Tcm and Tn populations of
CD8
+ T cells between the three different groups (Fig. 3C), and
with respect to the CD8
+ Tem cells, significantly higher number
were observed in the Viremic group relative to that in the LTNP
animals (36886380 versus 18736109), but no differences were
noted between the LTNP and the Chronic groups (18736109
versus 23816299). Thus, both the total and the Tcm subset of
CD4
+ T cells were significantly lower, in the Chronic group
compared to those in the LTNP group, while no such differences
were observed for the CD8
+ T cells subsets. Our results are in line
with observations reported in the literature that showed loss of
CD4 Tcm subset as an important underlying mechanism for the
deficiency to replenish gradually declining Tem subsets of both
CD4
+ and CD8
+ T cells in animals with chronic SIV infection
[23].
Differential association of the numbers of IFN-c and IL-2
producing total and memory subsets of CD4
+ and CD8
+ T
cells with viral loads
It is believed that different subsets of CD4
+ and CD8
+ T cells
play different functional roles with respect to antiviral immunity
[6]. To test the functional characteristics of total CD4
+ and CD8
+
T cells as well as their memory subsets in the three groups of
monkeys with different viral loads, we determined production of
IL-2 and/or IFN-c in response to in vitro stimulation with PMA+I
by cytokine flow cytometry analysis, a technique that allows for
precise quantification and phenotypic characterization of cytokine
producing T cells [24,25]. We observed substantial frequencies for
the numbers of IFN-c producing cells in the total as well as
memory subsets of both CD4
+ and CD8
+ T cells, and these
responses were restricted almost entirely to the population defined
by memory phenotype as shown for a representative animal from
each of the three groups studied (Figs. 4A and 4B). In general, we
observed CD4
+ as well as CD8
+ T cells producing both IFN-c and
IL-2 after PMA+I stimulation in all three groups exhibiting
different viral load levels, with the Tcm predominately producing
IL-2 and the Tem producing IFN-c. This is consistent with the
effector function of Tem subset and the precursor function of Tcm
subset to maintain the homeostasis of Tem during viral infections.
A summary of the total CD4
+ and CD8
+ T cells producing IFN-
c and/or IL-2 in response to in vitro stimulation with PMA+Ii n
all the tested animals is shown in Figs. 5A through 5C. The
average number of total CD4
+ T cells producing both the
cytokines, as shown in Fig. 5A, is significantly higher in the LTNP
group (9636168) compared to that in the Chronic group
(375692, p=0.0352) and also the Viremic group (3269,
P=0.006). However, unlike the total CD4
+ T cells, the mean
numbers of total CD8
+ T cells producing both IFN-c and IL-2 in
the three different groups of animals were not significantly
different from each other. With respect to the number of total
CD4
+ T cells producing a single cytokine in response to
stimulation with PMA+I the average frequencies of IL-2
producing CD4
+ T cells, as shown in Fig. 5B, animals in the
LTNP group showed significantly higher numbers (11256126)
compared to those in the Chronic group (222676) and the
Viremic group (33611). Also, the chronic group animals showed
significantly higher numbers of IL-2 producing CD4
+ T cells
relative to that in the Viremic group. Unlike the CD4
+ T cells,
there is no significant difference in the three groups of monkeys for
the frequencies of the numbers of total CD8
+ T cells producing IL-
2. We also compared the numbers of IFN-c producing total CD4
+
T cells in all the three groups of animals and observed that the
LTNP group showed significantly higher numbers than that in the
Viremic group but not the Chronic group and also no significant
differences were observed between the Chronic and the Viremic
group of animals (Fig. 5C). In contrast to the CD4
+ T cells, there
are no significant differences in the three groups of monkeys for
the numbers of total CD8
+ T cells producing IFN-c. These data
support the conclusion that the CD4
+ T cells, but not the CD8
+ T
cells, selectively exhibit a significant impairment in the IL-2
producing capacity, but not IFN-c in the Chronic group of
monkeys with higher viral loads, relative that in the LTNP group
of monkeys with low to undetectable plasma viral loads, even
though both these groups of animals exhibited no signs of disease.
Similar to the total CD4
+ T cells, significantly higher numbers
of duel cytokine producing CD4
+ Tcm cells subsets were observed
in LTNP group (7286124), followed by Chronic (277677) and
then the Viremic group (0.1560.06) as shown in Fig. 6A. With
respect to the CD8
+ Tcm cells, we obtained results similar to that
of the total CD8
+ T cells, in that the average numbers of total
CD8
+ Tcm cells producing IFN-c and IL-2 in the three groups are
not different from each other (Figs. 6A). Analyses of Tcm subset of
CD4
+ T cells producing single cytokine revealed impairment for
IL-2 production, but not IFN-c production in the Chronic group
of animals in terms of significantly lower numbers compared to
those in the LTNP group while production of neither IL-2 nor
IFN-c was different for the Tcm subset of CD8
+ T cells between
these two groups (Figs. 6B–C). With respect to the CD4
+ Tem cells
subsets, only very few numbers of CD4
+ Tem cells producing IL-2
were seen in the three different groups (Fig. 7B). We observed
significant difference only between the LTNP group and the
Viremic group, but not between the LTNP and the Chronic or the
Viremic and the Chronic groups for IFN-c and/or IL-2
production in response to PMA+I stimulation (Figs. 7A to C).
For the CD8
+ Tem population cells producing IL-2 and IFN-c as
well as IFN-c alone were not significantly different between the
three groups.
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PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e19607Figure 3. Flow cytometry analyses for the distribution of the memory subsets of the CD4
+ and CD8
+ T cells. Panel A:d a t af r o ma
representative animal from each of the three groups with different viral loads: Long-term non-progressors (LTNP), chronic viremia (Chronic), and highly
viremic (Viremic). The memory cells were differentiated on the basis of CD28 and CD95 expression into naı ¨ve (Tn CD28
+CD95
2), central memory (Tcm CD28
+
CD95
+) and effector memory (Tem CD28
2 CD95
+)s u b s e t s .Panels B and C: comparison of the average values for the numbers of the different memory
subsets of CD4
+T cells (B)a n dC D 8
+Tc e l l s( C) in all the animals tested in the LTNP, Chronic and Viremic groups of monkeys. The data are shown as the mean
6 SEM. The Horizontal bars represent the group mean, error bars represent SEM. Statistical differences between groups are indicated by the p values.
doi:10.1371/journal.pone.0019607.g003
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PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19607Figure 4. Flow cytometry analyses for the patterns of IFN-c and/or IL-2 production profile of total as well as the Tcm and Tem
memory subsets of CD4
+ T cells (A) and CD8
+ T cells (B) in a representative animal from each of the three groups with different viral
loads: Long-term non-progressors (LTNP), chronic viremia (Chronic), and highly viremic (Viremic).
doi:10.1371/journal.pone.0019607.g004
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generally rely on IFN-c production as a typical read out but
accruing data suggest that IL-2 secreting CD4
+ T cells represent a
key component of an effective immune response [26,27]. Since IL-
2 is an essential growth factor for all subtypes of T cells, it is
believed that the Tcm subset of CD4
+ T cells by virtue of strong
proliferation capacity combined with IL-2 producing ability are
necessary for the continuous replenishment of Tem subsets that
are the main effector population but depleted in acute as well as
chronic phases of HIV/SIV infections. Since CD4
+ T cells
constitute the major IL-2 producing population that is important
for maintaining functional integrity of other immune effectors
including CD8
+ T cells, a loss of IL-2 producing capacity of CD4
+
T cells could produce a domino effect eventually for the overall
immune deficiency. Therefore, our observation of the functional
impairment of the total as well as Tcm subsets of CD4
+ T cells, in
Figure 5. Comparison of the average values for the numbers of cytokine producing total CD4
+ and CD8
+ T cells in LTNP, Chronic
and Viremic groups of animals: IFN-c and IL-2 (A), IL-2 (B), and IFN-c (C). The data are shown as the mean 6 SEM. The Horizontal bars
represent the group mean, error bars represent SEM. Statistical differences between groups are indicated by the p values.
doi:10.1371/journal.pone.0019607.g005
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interpreted as an important event to predict future immunodefi-
ciency in the chronically infected animals. Analyses similar to our
present study in a bigger cohort of infected animals followed
prospectively would be important to further substantiate the
importance of selective deficiency in one or more cytokine
producing memory subset of CD4 T cells as a preferred predictive
marker of disease progression.
In summary, results from this investigation suggest functional
impairment of CD4
+ T cells, specifically the Tcm subset in the
animals with chronic infection but no clinical symptoms of disease,
as potentially an earliest form of immune dysfunction that may
predict the ensuing disease progression in HIV infection.
Importantly, this functional impairment of CD4 Tcm cells could
be detected using relatively robust, but non-specific, immune
stimulation reagents (PMA+I). This is specifically useful in
Figure 6. Comparison of the average values for the numbers of cytokine producing central memory CD4
+ and CD8
+ T cells (Tcm) in
LTNP, Chronic and Viremic groups of animals: IFN-c and IL-2 (A), IL-2 (B), and IFN-c (C). The data are shown as the mean 6 SEM. The
Horizontal bars represent the group mean, error bars represent SEM. Statistical differences between groups are indicated by the p values.
doi:10.1371/journal.pone.0019607.g006
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PLoS ONE | www.plosone.org 9 May 2011 | Volume 6 | Issue 5 | e19607situations of chronic infection where antigen-specific effector cells
are in limiting numbers that preclude detailed analyses requiring
stimulation with multiple viral antigens. Another important
finding is that the impairment of CD4
+ T cell function preceded
the more commonly employed predictive marker, which is CD8
+
T cell function, based on reports that showed disease progression
to correlate with exhausted CD8
+ T cells in HIV-infected humans
as well as in animal models as determined by changes in the
expression of phenotypic markers such as PD1 that indicate
functional anergy [28]. It has therefore been generally believed
that the exhausted phenotype would be indicative of functional
impairment, while the current study actually analyzed for and
detected functional impairment, specifically in the CD4
+ T cells as
a potentially earliest biomarker for disease progression. Our results
are in line with observations from Louis Picker’s group [23] who
showed loss of CD4 Tcm population, and thereby their essential
role as precursors for Tem cells, to underline the deficiency to
replenish gradually declining Tem cells. Our data further adds to
Figure 7. Comparison of the average values for the numbers of cytokine producing effector memory CD4
+ and CD8
+ T cells (Tem) in
LTNP, Chronic and Viremic groups of animals: IFN-c and IL-2 (A), IL-2 (B), and IFN-c (C). The data are shown as the mean 6 SEM. The
Horizontal bars represent the group mean, error bars represent SEM. Statistical differences between groups are indicated by the p values.
doi:10.1371/journal.pone.0019607.g007
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PLoS ONE | www.plosone.org 10 May 2011 | Volume 6 | Issue 5 | e19607this conclusion by providing functional assessment of this
important CD4 memory subset of T cells. After the major
destruction of memory cells during the acute phase infection, a
dramatic proliferation of Tcm occurs, probably as part of the
homeostatic mechanisms to compensate for the loss [20]. Based on
such observations it is suggested that the decline of CD4 Tcm
subset may be the critical trigger that serves as the initiating event
for the immune deficiency in general towards onset of AIDS in the
macaque model, and by extrapolation to HIV infected humans
[23]. Our results showing deficiency of total and central memory
CD4 T cells in terms of inability to produce IL-2 alone or in
combination with IFN-c in response to non-specific stimulation
further support a possible role for this functional phenotype that
could be detected potentially by relatively simplistic routine
analyses in clinical settings. Plasma viral load and CD4 cell counts
are currently the major criteria for initiating treatment with highly
active antiretroviral therapy. Some recent reports call attention to
the doubt as when treatment should be initiated [5,29,30]. We
believe that the simple analyses employing the robust non-specific
stimulation used in this investigation, if conducted in prospective
manner, could detect the potential triggering events of disease
progression and therefore may aid in better designing of clinical
management strategies for HIV-AIDS patients in terms of early
intervention.
Supporting Information
Figure S1 Numbers of peripheral blood CD4
+ T cells and
plasma viral loads in each of the three groups of animals for the
present investigation that were used in the past for vaccine studies.
Changes in the CD4
+ T cell counts and viral loads (viral RNA
copy equivalents/ml of plasma) for the LTNP group (A and B,
respectively), Chronic group (C and D, respectively), and Viremic
group (E and F, respectively) were recorded for approximately one
year post-infection with SHIV. See Methods section for experi-
mental details.
(TIF)
Figure S2 Typical results showing IFN-c and/or IL-2 produc-
tion profile of total as well as naı ¨ve and memory subsets of CD4
+ T
cells (A) and CD8
+ T cells (B) in the PBMC of a representative
animal in response to stimulation with PMA + Ionomycin or
medium (negative control).
(TIF)
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